ARTICLE | Distillery Therapeutics
Neurology
December 5, 2017 7:35 PM UTC
Mouse studies suggest MaR1 could help treat acute spinal cord injury (SCI). In a mouse model of SCI, daily IV injection of MaR1 for seven days increased locomotor recovery, myelin content at the injur...
BCIQ Target Profiles